ASX ANNOUNCEMENT 22 October 2026 Director Resignation Melbourne, Australia; 22 October 2026: Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), advises that Dr Paul Wotton will resign as a Director, effective from the conclusion of the Company’s Annual General...
Paul Wotton to Resign as Director from AGM
Filed with ASX · · 1 page · English
Release
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Unmarketable Parcel Sale Facility
- Notification of buy-back - CYP
- Letter to Ineligible Shareholders-Entitlement Offer
- Letter to Eligible Shareholders-Entitlement Offer
- Replacement Target Market Determination
Later from Cynata Therapeutics
- Letter to Shareholders, Notice of AGM & Proxy Form
- September 2026 Quarterly Activity Report & Appendix 4C
- Results of Fully Underwritten Entitlement Offer
- Consultancy Agreement
- Application for quotation of securities - CYP
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics